7Baggers
Quarterly
Annual
    Unit: USD2025-09-30 2025-06-30 2025-03-31 2024-09-30 2024-06-30 2024-03-31 2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2022-06-30 2022-03-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30 2020-06-30 2020-03-31 2019-09-30 2019-06-30 2019-03-31 2018-09-30 2018-06-30 2018-03-31 2017-09-30 2017-06-30 2017-03-31 2016-09-30 2016-06-30 2016-03-31 2015-09-30 2015-06-30 2015-03-31 2014-09-30 2014-06-30 2014-03-31 2013-09-30 2013-06-30 2013-03-31 
      
    		                                         
      net cash from operating activities
    		3,567,000,000 2,187,000,000 4,262,000,000 4,169,000,000 3,490,000,000 2,328,000,000 3,475,000,000 3,038,000,000 2,026,000,000 2,534,000,000 4,278,000,000 4,438,000,000 1,954,000,000 3,506,000,000 2,254,000,000 1,496,000,000 5,153,000,000 3,793,000,000 846,000,000 1,847,000,000 4,146,000,000 2,387,000,000 2,072,000,000 3,533,000,000 5,608,000,000 1,296,000,000 4,734,000,000 3,401,000,000 2,098,000,000 2,928,000,000 4,291,000,000 1,964,000,000 2,639,000,000 4,202,000,000 2,686,000,000 4,029,000,000 4,437,000,000 2,484,000,000 2,670,000,000 4,581,000,000 2,733,000,000 
      cash flows from investing activities
    		                                         
      sales, maturities and repayments of:
    		                                         
      fixed maturity securities available-for-sale
    		15,425,000,000 13,441,000,000 14,062,000,000 14,515,000,000 15,371,000,000 11,469,000,000 13,097,000,000 13,678,000,000 18,737,000,000 22,557,000,000 18,365,000,000 28,278,000,000 19,737,000,000 19,579,000,000 19,223,000,000 24,976,000,000 21,107,000,000 16,838,000,000 20,656,000,000 19,378,000,000 14,969,000,000 20,449,000,000 21,606,000,000                   
      equity securities
    		42,000,000 45,000,000 9,000,000 45,000,000 7,000,000 37,000,000 80,000,000 866,000,000 61,000,000 252,000,000 148,000,000 89,000,000 384,000,000 141,000,000 179,000,000 156,000,000 105,000,000 137,000,000 100,000,000 25,000,000 37,000,000 34,000,000 149,000,000 43,000,000 93,000,000 187,000,000 452,000,000 264,000,000 188,000,000 126,000,000 262,000,000 631,000,000 294,000,000 126,000,000 58,000,000 135,000,000 248,000,000 72,000,000 118,000,000 200,000,000 249,000,000 
      mortgage loans
    		2,827,000,000 3,187,000,000 3,234,000,000 2,426,000,000 2,560,000,000 2,217,000,000 2,224,000,000 3,002,000,000 1,345,000,000 1,796,000,000 2,298,000,000 3,281,000,000 3,404,000,000 4,066,000,000 4,963,000,000 3,663,000,000 3,452,000,000 2,791,000,000 2,236,000,000 2,821,000,000 2,870,000,000 3,296,000,000 1,769,000,000 2,537,000,000 2,265,000,000 2,076,000,000 2,367,000,000 2,578,000,000 1,776,000,000 3,767,000,000 3,894,000,000 2,857,000,000 3,281,000,000 3,775,000,000 2,719,000,000 4,360,000,000 3,584,000,000 2,973,000,000 2,967,000,000 2,523,000,000 2,510,000,000 
      real estate and real estate joint ventures
    		174,000,000 24,000,000 48,000,000 264,000,000 155,000,000 143,000,000 47,000,000 50,000,000 26,000,000 630,000,000 28,000,000 355,000,000 83,000,000 424,000,000 630,000,000 106,000,000 10,000,000 7,000,000 13,000,000 90,000,000 414,000,000 35,000,000 103,000,000 139,000,000 294,000,000 128,000,000 199,000,000 451,000,000 39,000,000 152,000,000 115,000,000 56,000,000 1,141,000,000 223,000,000 280,000,000 147,000,000 125,000,000 260,000,000 52,000,000 185,000,000 86,000,000 
      other limited partnership interests
    		165,000,000 203,000,000 301,000,000 216,000,000 224,000,000 402,000,000 157,000,000 247,000,000 294,000,000 309,000,000 79,000,000 326,000,000 901,000,000 180,000,000 158,000,000 174,000,000 292,000,000 145,000,000 14,000,000 146,000,000 146,000,000 152,000,000 250,000,000 177,000,000 198,000,000 139,000,000 193,000,000 228,000,000 461,000,000 575,000,000 155,000,000 295,000,000 277,000,000 303,000,000 279,000,000 172,000,000 163,000,000 220,000,000 36,000,000 285,000,000 225,000,000 
      short-term investments
    		4,139,000,000 3,296,000,000 4,143,000,000 2,102,000,000 3,888,000,000 3,753,000,000 4,418,000,000 2,814,000,000 3,448,000,000                                 
      purchases and originations of:
    		                                         
      cash received in connection with freestanding derivatives
    		723,000,000 635,000,000 803,000,000 691,000,000 531,000,000 503,000,000 514,000,000 246,000,000 1,200,000,000 1,349,000,000 662,000,000 1,421,000,000 1,092,000,000 805,000,000 411,000,000 1,358,000,000 -276,000,000 -133,000,000 269,000,000 4,987,000,000 1,253,000,000 703,000,000 1,021,000,000 754,000,000 402,000,000 1,974,000,000 945,000,000 1,430,000,000 2,515,000,000 780,000,000 1,141,000,000 1,337,000,000 852,000,000 577,000,000 947,000,000 274,000,000 308,000,000 395,000,000 556,000,000 447,000,000 330,000,000 
      cash paid in connection with freestanding derivatives
    		-1,205,000,000 -946,000,000 -1,013,000,000 -522,000,000 -1,209,000,000 -1,052,000,000 -1,474,000,000 -1,196,000,000 -1,546,000,000 -1,725,000,000 -1,550,000,000 -2,604,000,000 -1,914,000,000 -1,192,000,000 -814,000,000 -4,788,000,000 -1,347,000,000 -883,000,000 -577,000,000 -1,440,000,000 -832,000,000 -1,231,000,000 -1,231,000,000 -1,107,000,000 -446,000,000 -2,192,000,000 -1,706,000,000 -2,326,000,000 -3,372,000,000 -1,608,000,000 -1,536,000,000 -1,173,000,000 -287,000,000 -1,106,000,000 -1,494,000,000 -527,000,000 -958,000,000 -1,045,000,000 -1,293,000,000 -1,872,000,000 -2,428,000,000 
      purchases of investments in operating joint ventures
    		         0 0 0 -240,000,000                 0            
      net change in policy loans
    		44,000,000 57,000,000 -87,000,000 -42,000,000 63,000,000 -80,000,000 26,000,000 20,000,000 -4,000,000 16,000,000 9,000,000 44,000,000 35,000,000 42,000,000 52,000,000 85,000,000 144,000,000 94,000,000 -8,000,000 20,000,000 10,000,000 -20,000,000 16,000,000 -20,000,000 -17,000,000 -25,000,000 -22,000,000 26,000,000 -20,000,000 94,000,000 22,000,000 85,000,000 15,000,000 2,000,000 -7,000,000 -14,000,000 -3,000,000 -2,000,000 18,000,000 -59,000,000 -52,000,000 
      net change in other invested assets
    		-103,000,000 100,000,000 457,000,000 49,000,000 -226,000,000 -280,000,000 56,000,000 -890,000,000 -243,000,000 38,000,000 -87,000,000 -514,000,000 -223,000,000 -307,000,000 63,000,000 -23,000,000 -121,000,000 -120,000,000 66,000,000 -1,000,000 -306,000,000 118,000,000 -53,000,000 10,000,000 118,000,000 46,000,000 22,000,000 -163,000,000 -43,000,000 -191,000,000 -119,000,000 252,000,000 -93,000,000 -90,000,000 -167,000,000 -31,000,000 -335,000,000 115,000,000 53,000,000 52,000,000 -226,000,000 
      other
    		-13,000,000 -23,000,000 -51,000,000 -57,000,000 -113,000,000 -14,000,000 -18,000,000 -10,000,000 -97,000,000 274,000,000 5,000,000 -115,000,000 81,000,000 -36,000,000 -23,000,000 17,000,000 215,000,000 -29,000,000 240,000,000 -75,000,000 -37,000,000 -37,000,000 -55,000,000 12,000,000 -74,000,000 86,000,000 -62,000,000 -96,000,000 -98,000,000 -139,000,000 -222,000,000 -23,000,000 -41,000,000 -64,000,000 -86,000,000 -21,000,000 -44,000,000 -66,000,000 -40,000,000 -18,000,000 40,000,000 
      net cash from investing activities
    		-5,018,000,000 -2,981,000,000 -3,322,000,000 -2,162,000,000 -1,340,000,000 -2,627,000,000 -2,972,000,000 -6,346,000,000 -1,504,000,000 -197,000,000 -4,112,000,000 2,115,000,000 -426,000,000 -8,280,000,000 1,009,000,000 -1,054,000,000 -2,162,000,000 -6,679,000,000 -1,391,000,000 -8,337,000,000 -5,351,000,000 557,000,000 -5,699,000,000 -6,228,000,000 -4,279,000,000 -485,000,000 -10,009,000,000 -2,873,000,000 -4,276,000,000 -4,678,000,000 -4,169,000,000 -5,739,000,000 -147,000,000 140,000,000 -6,900,000,000 -4,969,000,000 -8,864,000,000 2,164,000,000 1,278,000,000 1,866,000,000 -9,719,000,000 
      cash flows from financing activities
    		                                         
      policyholder account balances - deposits
    		27,181,000,000 27,064,000,000 28,692,000,000 24,858,000,000 25,567,000,000 24,444,000,000 22,458,000,000                                   
      policyholder account balances - withdrawals
    		-25,480,000,000 -24,753,000,000 -26,916,000,000 -24,269,000,000 -24,692,000,000 -23,373,000,000 -21,821,000,000                                   
      net change in payables for collateral under securities loaned and other transactions
    		28,000,000 -351,000,000 233,000,000 -779,000,000 335,000,000 50,000,000 -955,000,000 -906,000,000 -1,066,000,000 -4,128,000,000 1,207,000,000 -6,478,000,000 -1,331,000,000 773,000,000 1,932,000,000 -1,426,000,000 -4,487,000,000 624,000,000 -1,395,000,000 8,796,000,000 2,978,000,000 337,000,000 388,000,000 -914,000,000 966,000,000 667,000,000 1,111,000,000 814,000,000 391,000,000 -1,367,000,000 4,433,000,000 4,161,000,000 2,459,000,000 -1,780,000,000 1,985,000,000 590,000,000 833,000,000 2,058,000,000 -1,381,000,000 -968,000,000 528,000,000 
      long-term debt issued
    		30,000,000 624,000,000 89,000,000 277,000,000 512,000,000 758,000,000 1,003,000,000 0 1,000,000,000 0 1,007,000,000   14,000,000   0 50,000,000 0 1,074,000,000 0   10,000,000 0 14,000,000 668,000,000      86,000,000 0 1,492,000,000 0      
      long-term debt repaid
    		-51,000,000 -3,000,000 -555,000,000 -1,000,000 -1,477,000,000 -264,000,000 -8,000,000 -7,000,000 -1,012,000,000 -8,000,000 -54,000,000 -13,000,000 -10,000,000 -512,000,000 -13,000,000 -15,000,000 -4,000,000 -82,000,000 -7,000,000 -6,000,000 -6,000,000 -885,000,000 -10,000,000 -1,111,000,000 -168,000,000 -32,000,000 -51,000,000 -5,000,000 -4,000,000 -9,000,000 -1,259,000,000 -5,000,000 -58,000,000 -1,013,000,000 -7,000,000 -318,000,000 -1,024,000,000 -1,460,000,000 -409,000,000 -116,000,000 -240,000,000 
      collateral financing arrangement repaid
    		-40,000,000 -25,000,000 -13,000,000 -26,000,000 -35,000,000 -47,000,000 -24,000,000 -29,000,000 -12,000,000 -13,000,000 -12,000,000 -13,000,000 -12,000,000 -12,000,000 -15,000,000 -12,000,000 -79,000,000 -44,000,000 -13,000,000 -12,000,000 -13,000,000                     
      subordinated debt securities issued
    		0 0 1,000,000,000                                       
      derivatives with certain financing elements and other derivative-related transactions
    		-58,000,000 -3,000,000 -71,000,000 109,000,000 -95,000,000 -55,000,000                                    
      proceeds from mortgage loan secured financing
    		17,000,000 268,000,000 66,000,000 55,000,000 50,000,000 42,000,000 63,000,000                                   
      repayments of mortgage loan secured financing
    		-205,000,000 -417,000,000 -255,000,000 -159,000,000 -258,000,000 -161,000,000 -62,000,000                                   
      treasury stock acquired in connection with share repurchases
    		-502,000,000 -510,000,000 -1,411,000,000 -774,000,000 -855,000,000 -1,172,000,000 -792,000,000 -672,000,000 -780,000,000 -596,000,000 -674,000,000 -1,116,000,000 -940,000,000 -1,015,000,000 -1,113,000,000 -999,000,000 -571,000,000 -80,000,000 0 -500,000,000 -785,000,000 -750,000,000 -500,000,000 -636,000,000 -1,115,000,000 -1,041,000,000 -495,000,000 -952,000,000 -858,000,000 0 0 -70,000,000 -107,000,000 -14,000,000 -986,000,000 -439,000,000      
      redemption of preferred stock
    		             0                            
      preferred stock redemption premium
    		             0                            
      dividends on preferred stock
    		-66,000,000 -31,000,000 -66,000,000 -67,000,000 -34,000,000 -67,000,000 -67,000,000 -32,000,000 -66,000,000 -29,000,000 -64,000,000 -29,000,000 -63,000,000 -63,000,000 -35,000,000 -68,000,000 -34,000,000 -59,000,000 -77,000,000 -32,000,000 -32,000,000 -57,000,000 -32,000,000 -32,000,000 -46,000,000 -6,000,000 -6,000,000 -46,000,000 -6,000,000 -6,000,000 -46,000,000 -6,000,000 -6,000,000 -31,000,000 -30,000,000 -30,000,000 -31,000,000 -30,000,000 -30,000,000 -31,000,000 -30,000,000 
      dividends on common stock
    		-378,000,000 -382,000,000 -374,000,000 -383,000,000 -389,000,000 -377,000,000 -392,000,000 -399,000,000 -389,000,000 -393,000,000 -400,000,000 -408,000,000 -397,000,000 -413,000,000 -421,000,000 -408,000,000 -415,000,000 -419,000,000 -419,000,000 -404,000,000 -413,000,000 -419,000,000 -405,000,000 -419,000,000 -428,000,000 -416,000,000 -427,000,000 -431,000,000 -437,000,000 -441,000,000 -441,000,000 -413,000,000 -420,000,000 -420,000,000 -394,000,000 -395,000,000 -395,000,000 -311,000,000 -303,000,000 -302,000,000 -203,000,000 
      net cash from financing activities
    		-508,000,000 1,449,000,000 220,000,000 -1,146,000,000 -1,205,000,000 -261,000,000 -848,000,000 379,000,000 -2,295,000,000 -4,701,000,000 1,775,000,000 -9,133,000,000 1,951,000,000 -1,108,000,000 1,632,000,000 -564,000,000 -6,993,000,000 2,885,000,000 680,000,000 14,157,000,000 2,327,000,000 934,000,000 2,316,000,000 -1,081,000,000 1,394,000,000 218,000,000 883,000,000 -693,000,000 1,499,000,000 612,000,000 3,376,000,000 4,240,000,000 -288,000,000 -4,287,000,000 1,723,000,000 2,411,000,000 3,225,000,000 -3,659,000,000 -1,794,000,000 -7,114,000,000 1,324,000,000 
      effect of change in foreign currency exchange rates on cash and cash equivalents balances
    		14,000,000 197,000,000 98,000,000 118,000,000 1,000,000 -239,000,000 -160,000,000 -110,000,000 34,000,000 359,000,000 -289,000,000 -383,000,000 -84,000,000 -200,000,000 0 -192,000,000 157,000,000 117,000,000 60,000,000 -171,000,000 -105,000,000 51,000,000 -4,000,000 -46,000,000 -338,000,000 197,000,000 96,000,000 73,000,000 213,000,000 -46,000,000 279,000,000 73,000,000 -62,000,000 -108,000,000 -190,000,000 -81,000,000 22,000,000 -1,000,000 38,000,000 -132,000,000 -93,000,000 
      change in cash and cash equivalents
    		-1,945,000,000 852,000,000 1,258,000,000 979,000,000 946,000,000 -799,000,000 -505,000,000 -3,039,000,000 -1,739,000,000 -2,005,000,000 1,652,000,000 -2,963,000,000 3,395,000,000 -6,082,000,000 4,895,000,000 -314,000,000 -3,845,000,000 116,000,000 195,000,000 7,496,000,000 1,017,000,000 3,929,000,000 -1,315,000,000 -3,822,000,000 2,385,000,000 1,226,000,000 -4,296,000,000 -92,000,000 -466,000,000 -1,184,000,000 3,777,000,000 538,000,000 2,142,000,000 -53,000,000 -2,681,000,000 1,390,000,000 -1,180,000,000 988,000,000 2,192,000,000 -799,000,000 -5,755,000,000 
      cash and cash equivalents, beginning of period
    		0 0 20,068,000,000 0 0 20,639,000,000 0 0 20,195,000,000  0 0 20,047,000,000 0 0 19,795,000,000  0 0 16,598,000,000 0 0 15,821,000,000 0 0 12,701,000,000 0 0 17,877,000,000 0 0 12,752,000,000 0 0 10,808,000,000 0 0 7,585,000,000 0 0 15,738,000,000 
      cash and cash equivalents, end of period
    		-1,945,000,000 852,000,000 21,326,000,000 979,000,000 946,000,000 19,840,000,000 -505,000,000 -3,039,000,000 18,456,000,000  1,652,000,000 -2,940,000,000 23,488,000,000 -6,081,000,000 5,402,000,000 19,635,000,000  116,000,000 195,000,000 24,094,000,000 1,017,000,000 3,929,000,000 14,506,000,000 -3,822,000,000 2,385,000,000 13,927,000,000 -4,296,000,000 -92,000,000 17,411,000,000 -1,184,000,000 3,777,000,000 13,290,000,000 2,142,000,000 -53,000,000 8,127,000,000 1,390,000,000 -1,180,000,000 8,573,000,000 2,192,000,000 -799,000,000 9,983,000,000 
      sales of businesses, net of cash and cash equivalents disposed of 0 and 67, respectively
    		                                         
      financing element on certain derivative instruments and other derivative related transactions
    		      -228,000,000 -2,000,000 60,000,000   16,000,000 105,000,000 -13,000,000 -8,000,000 326,000,000 62,000,000 134,000,000 -75,000,000 -167,000,000 32,000,000 15,000,000 -29,000,000 -27,000,000 -25,000,000 37,000,000 -15,000,000 -282,000,000 188,000,000             
      cash and cash equivalents, including subsidiaries held-for-sale, beginning of period
    		      0 0 20,195,000,000  0 0 20,116,000,000                             
      cash and cash equivalents, including subsidiaries held-for-sale, end of period
    		      -505,000,000 -3,039,000,000 18,456,000,000  1,652,000,000 -2,963,000,000 23,511,000,000                             
      cash and cash equivalents, subsidiaries held-for-sale, beginning of period
    		          0 0 69,000,000                             
      cash and cash equivalents, subsidiaries held-for-sale, end of period
    		            23,000,000                             
      policyholder account balances:
    		                                         
      deposits
    		        26,963,000,000 19,329,000,000 27,598,000,000 27,774,000,000 28,335,000,000 24,671,000,000 25,143,000,000 25,722,000,000 19,871,000,000 23,506,000,000 25,300,000,000 24,820,000,000 24,134,000,000 21,620,000,000 23,891,000,000 25,179,000,000 21,997,000,000 24,861,000,000 22,711,000,000 23,583,000,000 21,271,000,000 23,877,000,000 21,423,000,000 19,925,000,000 24,950,000,000 21,970,000,000 22,463,000,000 27,008,000,000 27,843,000,000 19,004,000,000 18,661,000,000 20,137,000,000 21,370,000,000 
      withdrawals
    		        -26,885,000,000 -18,772,000,000 -26,686,000,000 -28,775,000,000 -23,653,000,000 -24,500,000,000 -23,468,000,000 -23,527,000,000 -20,395,000,000 -21,747,000,000 -22,632,000,000 -20,477,000,000 -23,710,000,000 -20,041,000,000 -20,904,000,000 -22,893,000,000 -20,529,000,000 -24,447,000,000 -19,846,000,000 -23,287,000,000 -19,100,000,000 -21,252,000,000 -20,583,000,000 -19,310,000,000 -26,568,000,000 -23,636,000,000 -22,736,000,000 -23,680,000,000 -24,993,000,000 -22,628,000,000 -19,289,000,000 -25,818,000,000 -20,034,000,000 
      cash flows from operating activities
    		                                         
      net income
    		                                         
      adjustments to reconcile net income to net cash from operating activities:
    		                                         
      depreciation and amortization expenses
    		                                         
      amortization of premiums and accretion of discounts associated with investments
    		                                         
      (gains) losses on investments and from sales of businesses
    		                                         
      (gains) losses on derivatives
    		                                         
      (income) income from equity method investments, net of dividends or distributions
    		                                         
      interest credited to policyholder account balances
    		                                         
      universal life and investment-type product policy fees
    		                                         
      change in contractholder-directed equity securities and fair value option securities
    		                                         
      change in accrued investment income
    		                                         
      change in premiums, reinsurance and other receivables
    		                                         
      change in deferred policy acquisition costs and value of business acquired
    		                                         
      change in income tax
    		                                         
      change in other assets
    		                                         
      change in insurance-related liabilities and policy-related balances
    		                                         
      change in other liabilities
    		                                         
      sales of businesses, net of cash and cash equivalents disposed of 67, 611 and 0, respectively
    		                                         
      purchases of businesses, net of cash received of 4, 0 and 191, respectively
    		                                         
      payables for collateral under securities loaned and other transactions:
    		                                         
      cash received for other transactions with tenors greater than three months
    		                0 100,000,000 0 50,000,000                      
      cash paid for other transactions with tenors greater than three months
    		             0 0 -100,000,000 0 -125,000,000 0 -50,000,000 0 -125,000,000 -75,000,000                   
      preferred stock issued, net of issuance costs
    		                0 989,000,000 0 972,000,000    0 780,000,000 494,000,000       -2,000,000         
      cash and cash equivalents, including subsidiaries held-for-sale, beginning of year
    		                                         
      cash and cash equivalents, including subsidiaries held-for-sale, end of year
    		                                         
      cash and cash equivalents, subsidiaries held-for-sale, beginning of year
    		                                         
      cash and cash equivalents, subsidiaries held-for-sale, end of year
    		                                         
      cash and cash equivalents, beginning of year
    		                                         
      cash and cash equivalents, end of year
    		                                         
      supplemental disclosures of cash flow information
    		                                         
      net cash paid (received) for:
    		                                         
      interest
    		                  290,000,000 136,000,000 137,000,000 362,000,000 148,000,000 217,000,000    319,000,000 255,000,000 252,000,000 374,000,000 249,000,000 249,000,000 373,000,000 214,000,000 218,000,000 378,000,000 245,000,000 273,000,000 354,000,000 264,000,000 
      income tax
    		                  165,000,000 -35,000,000 86,000,000 642,000,000 114,000,000 118,000,000    396,000,000 109,000,000 71,000,000 268,000,000 125,000,000 560,000,000 197,000,000 147,000,000 81,000,000 235,000,000 97,000,000 95,000,000 227,000,000 217,000,000 
      business acquisitions
    		                                         
      assets
    		                                         
      liabilities
    		                                         
      cash paid, excluding transaction costs
    		                                         
      non-cash transactions:
    		                                         
      fixed maturity securities available-for-sale received in connection with pension risk transfer transactions
    		                    0                     
      real estate and real estate joint ventures acquired in satisfaction of debt
    		                                      0 0 55,000,000 
      increase in equity securities due to in-kind distributions received from other limited partnership interests
    		                                         
      reclassification of certain other invested assets to contractholder-directed equity securities and fair value option securities
    		                                         
      sales of businesses, net of cash and cash equivalents disposed of 67 and 611, respectively
    		          0                               
      net change in short-term investments
    		          -2,387,000,000 233,000,000 3,986,000,000 -3,281,000,000 944,000,000 -828,000,000 -306,000,000 1,537,000,000 553,000,000 -2,125,000,000 -721,000,000 1,747,000,000 -545,000,000 -1,356,000,000 1,215,000,000 -160,000,000 -1,123,000,000 2,806,000,000 -1,892,000,000 -1,817,000,000 1,887,000,000 -2,302,000,000 -411,000,000 -543,000,000 -5,690,000,000 122,000,000 1,327,000,000 47,000,000 392,000,000 577,000,000 3,303,000,000 
      sales of businesses, net of cash and cash equivalents disposed of 611 and 0, respectively
    		             0                            
      cash and cash equivalents, including subsidiary held-for-sale, beginning of period
    		             0 0 20,560,000,000                          
      cash and cash equivalents, including subsidiary held-for-sale, end of period
    		             -6,082,000,000 4,895,000,000 20,246,000,000                          
      cash and cash equivalents, subsidiary held-for-sale, beginning of period
    		             0 0 765,000,000                          
      cash and cash equivalents, subsidiary held-for-sale, end of period
    		             -1,000,000 -507,000,000 611,000,000                          
      purchases of businesses, net of cash received of 191, 0 and 0, respectively
    		                                         
      cash and cash equivalents, including subsidiary held-for-sale, end of year
    		                                         
      cash and cash equivalents, subsidiary held-for-sale, end of year
    		                                         
      subsidiary held-for-sale
    		                                         
      assets held-for-sale
    		                                         
      liabilities held-for-sale
    		                                         
      net assets held-for-sale
    		                                         
      operating lease liability associated with the recognition of right-of-use assets
    		                                         
      brighthouse common stock exchange transaction
    		                                         
      reduction of long-term debt
    		                       0            0 0 413,000,000    
      reduction of fair value option securities
    		                       0                  
      reclassification of certain equity securities to other invested assets
    		                                         
      increase in policyholder account balances associated with funding agreement backed notes issued but not settled
    		                                         
      brighthouse common stock exchange transaction:
    		                                         
      collateral financing arrangements repaid
    		                      -12,000,000 -12,000,000 -23,000,000 -13,000,000 -16,000,000 -2,824,000,000 -12,000,000 -29,000,000 -14,000,000 -12,000,000 -12,000,000         
      purchases of:
    		                                         
      cash disposed due to distribution of brighthouse
    		                                         
      purchases of businesses
    		                                         
      distribution of brighthouse
    		                                         
      cash and cash equivalents, of disposed subsidiary, beginning of period
    		                                         
      cash and cash equivalents, of disposed subsidiary, end of period
    		                                         
      cash and cash equivalents, from continuing operations, beginning of period
    		                       0 0 12,701,000,000                
      cash and cash equivalents, from continuing operations, end of period
    		                       -3,822,000,000 2,385,000,000 13,927,000,000                
      fixed maturity securities available-for-sale received in connection with pension risk transfer transaction
    		                                         
      disposal of brighthouse
    		                                         
      assets disposed
    		                                         
      liabilities disposed
    		                                         
      net assets disposed
    		                                         
      cash disposed
    		                                         
      net non-cash disposed
    		                                         
      fixed maturity securities
    		                        28,444,000,000 26,053,000,000 19,424,000,000 24,034,000,000 23,086,000,000 34,109,000,000 32,410,000,000 35,095,000,000 31,443,000,000 42,218,000,000 35,647,000,000 28,393,000,000 28,890,000,000 27,904,000,000 31,298,000,000 34,650,000,000 30,024,000,000 
      fixed maturity securities received in connection with pension risk transfer transaction
    		                                         
      sales of businesses, net of cash and cash equivalents disposed of 0 and 135, respectively
    		                                         
      reduction of fixed maturity securities in connection with a reinsurance transaction
    		                             0 0 224,000,000          
      deconsolidation of operating joint venture:
    		                                         
      reduction of fixed maturity securities
    		                             0 0 917,000,000          
      reduction of noncontrolling interests
    		                             0 0 373,000,000          
      net change in short-term debt
    		                            18,000,000 -6,000,000      0 0 -75,000,000    
      cash received under repurchase agreements
    		                                0 0 199,000,000       
      cash paid under reverse repurchase agreements
    		                                0 0 -199,000,000       
      sales of businesses, net of cash and cash equivalents disposed of 135 and 0, respectively
    		                                         
      repurchase of preferred stock
    		                                -555,000,000         
      preferred stock repurchase premium
    		                                -15,000,000         
      fixed maturity securities received in connection with pension risk transfer transactions
    		                                         
      deconsolidation of operating joint venture
    		                                         
      sales of businesses, net of cash and cash equivalents disposed of 0 and 262, respectively
    		                                         
      purchases of investments in insurance joint ventures
    		                                   -28,000,000      
      cash received (paid) in connection with collateral financing arrangements
    		                                         
      fixed maturity securities received in connection with pension closeout transactions
    		                                         
      deconsolidation of metlife core property fund:
    		                                         
      reduction of redeemable noncontrolling interests
    		                                   0 0 774,000,000    
      reduction of real estate and real estate joint ventures
    		                                   0 0 1,132,000,000    
      sales of businesses, net of cash and cash equivalents disposed of 262 and 13, respectively
    		                                         
      sale of bank deposits
    		                                      0 0 -6,395,000,000 
      net change in bank deposits
    		                                      0 0 8,000,000 
      common stock issued, net of issuance costs
    		                                         
      deconsolidation of metlife core property fund
    		                                         
      sales of businesses, net of cash and cash equivalents disposed of 262 and 0, respectively
    		                                         
      dividends on common stock declared and unpaid
    		                                         
      sales of businesses
    		                                       0 373,000,000 
      supplemental disclosures of cash flow information:
    		                                         
      net change in securitized reverse residential mortgage loans
    		                                         
      sales of businesses, net of cash and cash equivalents disposed of 13 and 0, respectively
    		                                         
      net change in liability for securitized reverse residential mortgage loans
    		                                         
      redemption of advances agreements in long-term debt
    		                                         
      issuance of funding agreements in policyholder account balances
    		                                         
      sale of interest in joint venture
    		                                         
      cash received in connection with collateral financing arrangements
    		                                         
      cash paid in connection with collateral financing arrangements
    		                                         
      debt issuance costs
    		                                         
      stock options exercised
    		                                         
      redemption of convertible preferred stock
    		                                         
      net cash paid during the period for:
    		                                         
      non-cash transactions during the period:
    		                                         
    The information provided in this report is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.